Gynecology

Genetics Issues

With the introduction of ultrasound into clinical obstetric care, the in-utero identification of vertebrate structural anomalies has become routine. The ultrasound technology is improving and now allowing detection of most major anomalies, karyotyping and chromosomal microarray analysis can offer disease-specific counselling

In the context of maternal vertebrate medication so as to boost the health care of new-burns and their families. With advances in antepartum imaging, we tend to area unit progressively ready to find birth defects prenatally and use this data to optimize perinatal and infant management. Introduction of next-gene sequencing technologies into perinatal care is that the logical next step as body microarray analysis has currently transitioned into routine antepartum care.

Molecular genetic diagnostics have improved our ability to more precisely identify the underlying cause of birth defects and provide additional prognostic information to improve prenatal and postnatal management. There are many clinical benefits including increasingly precise prognostic information to alert the clinician to other anomalies or medical/developmental problems associated with the genomic findings, reducing the need for costly postnatal diagnostic tests and allowing prenatal planning of mode and hospital of delivery to optimize early treatment.